The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.
 
Ranit Aharonov
Employment - Pangaea Biotech
Leadership - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Gal Dinstag
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Eldad Shulman
Stock and Other Ownership Interests - Pangaea Biotech
 
Efrat Elis
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Doreen Ben-Zvi
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Omer Tirosh
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Eden Maimon
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Sanju SInha
No Relationships to Disclose
 
Nishanth Ulhas Nair
No Relationships to Disclose
 
Andrea B. Apolo
No Relationships to Disclose
 
Stanley Lipkowitz
No Relationships to Disclose
 
Raanan Berger
Stock and Other Ownership Interests - Belong
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche Israel
Consulting or Advisory Role - Belong; BMS; MSD Oncology
Speakers' Bureau - BMS; Mitra Biotech; MSD Oncology
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Mitra Biotech; MSD
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; CureMetrix; IDbyDNA
Honoraria - AACR; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Bicara Therapeutics; Biological Dynamics; Caris Life Sciences; Daiichi Sankyo; Datar Genomics; Eisai; EOM Pharmaceuticals; Gaido; Iylon; Loxo; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Prosperdtx; Regeneron; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - NeoGenomics Laboratories; Roche
Research Funding - Biological Dynamics (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - NCI SWOG; TargetCancer Foundation
 
Antonios Papanicolau-Sengos
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Padma Sheila Rajagopal
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose
 
Kenneth D. Aldape
No Relationships to Disclose
 
Tuvik Beker
Employment - Pangaea Biotech
Leadership - MedAware; Pangaea Biotech
Stock and Other Ownership Interests - MedAware; Pangaea Biotech
Patents, Royalties, Other Intellectual Property - Patents and pending patents assigned to MedAware and Pangea
 
Eytan Ruppin
Stock and Other Ownership Interests - MedAware; Metabomed
Consulting or Advisory Role - Pangaea Biotech
Patents, Royalties, Other Intellectual Property - Patent applications have been submitted by Te-Aviv University, U Maryland and NCI for synthetic lethality and expression deconvolution computational analysis approaches
(OPTIONAL) Uncompensated Relationships - Pangea